Muscle Atrophy: Clinical Trials

2 trials for Muscle Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Muscle Atrophy: new trials by email Literature Review of Muscle Atrophy trials Research Report on Muscle Atrophy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
IMM01-STEM - Muscle Atrophy
Phase 1 / Phase 2CompletedImmunis, Inc.132022-09-132026-09-09
Electrical Stimulation for Critically Ill Covid-19 Patients
Electrical Stimulation, Electrical Stimulation - Sham - Covid19, Muscle Atrophy
Phase 1CompletedBaylor College of Medicine192020-12-222023-02-16

Narrower conditions

Muscular Atrophy (2)  ·  COVID-19 (1)  ·  Muscle Weakness (1)

Broader conditions

Atrophy (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Manifestations (2)  ·  Pathological Conditions, Anatomical (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)

Interventions

Electric Stimulation (1)

Sponsors

Baylor College of Medicine (1)  ·  Immunis, Inc. (1)

Countries

United States (2)

Top investigators

Tom Lane, PhD (1)

Results publications

PMID 36561714